Genmab — Januar 2018
-
Seeing Dara being used as example in "FDA Helps Streamline Approval Process for Supplemental Drug Indications" makes me feel comfortable about Dara processing speed within the FDA
-
Best of ASH 2017. Did the excitement over CAR T-cell therapies news live up to expectations? What new myeloma drugs and treatment paradigms are now on the horizon? Dr. Brian G.M. Durie explains the most significant findings presented at the 59th American Society of Hematology annual conference for patients, caregivers, and other members of the myeloma community. https://www.myeloma.org/videos/best-ash-2017
-
Kan ikke huske om denne har været nævnt om Ofatumumab http://www.nejm.org/doi/full/10.1056/NEJMc1714146#t=article
-
Og så er Ocrevus blevet godkendt i EU mod PPMS og RRMS http://mstidsskrift.dk/behandling/medicin/154-ocrevus-godkendt-af-eu-mod-ppms.html
-
AQR har øget sine shorts til 1,35% https://oasm.finanstilsynet.dk/dk/vismeddelelse.aspx?aid=e053abe3-f948-40fb-b310-2148747a47e4
-
God morgen.
-
Godmorgen
-
Vitus..."Eufori" er måske lige at stramme den. Det er ikke den stemning som har kendetegnet chatten her generelt i hverdagene med mindre der har været afgørende nyheder.
-
Vi er pt. i nyhedstørke...Den slags perioder har man i alle selskaber.
-
Det lægger altid en dæmper på snakkelysten - og behovet.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind